RAPP
NASDAQ · Pharmaceuticals
Rapport Therapeutics Inc
$27.08
-0.38 (-1.38%)
Open$27.46
Previous Close$27.46
Day High$27.97
Day Low$26.97
52W High$42.27
52W Low$7.40
Volume—
Avg Volume282.3K
Market Cap1.37B
P/E Ratio—
EPS$-2.71
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+66.8% upside
Current
$27.08
$27.08
Target
$45.18
$45.18
$32.24
$45.18 avg
$61.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 234.18M | 211.21M | 206.84M |
| Net Income | 54.92M | 48.45M | 43.47M |
| Profit Margin | 23.5% | 22.9% | 21.0% |
| EBITDA | 80.71M | 80.88M | 78.48M |
| Free Cash Flow | 32.46M | 39.08M | 24.42M |
| Rev Growth | +10.7% | -0.4% | +18.1% |
| Debt/Equity | 0.72 | 0.64 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |